BioSpace News Archive

BioMidwest

BIO-TECHNE SETS A NEW STANDARD IN HIGHLY SENSITIVE RNA IMAGING WITH THE INTRODUCTION OF VIVID FLUORESCENT DYES FOR SPATIAL BIOLOGY

Bio-Techne Corporation (NASDAQ: TECH) today announced the introduction of 3 novel TSA Vivid Fluorophores for highly sensitive fluorescent detection of RNAs and proteins in cells and tissues.

October 12, 2022
·
2 min read
Business

Repligen to Report Third Quarter 2022 Financial ResultsWebcast and Conference Call to Be Held Tuesday, November 1, 2022 at 8:30 a.m. EDT

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2022 financial results on Tuesday, November 1, 2022.

October 12, 2022
·
2 min read
Business

Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer Vaccine

Moderna, Inc. and Merck today announced that Merck has exercised its option to jointly develop and commercialize personalized cancer vaccine (PCV) mRNA-4157/V940 pursuant to the terms of its existing Collaboration and License Agreement.

October 12, 2022
·
48 min read
Business

Coherus and Junshi Biosciences Announce Publication of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab

Coherus BioSciences, Inc. and Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced the publication of toripalimab plus chemotherapy for patients with treatment-naïve advanced non-small cell lung cancer: a multi-center randomized phase 3 trial (CHOICE-01) in the Journal of Clinical Oncology.

October 12, 2022
·
12 min read
Biotech Beach

Erasca Announces Four Poster Presentations at the Upcoming 34th EORTC-NCI-AACR Symposium

Erasca, Inc. (Nasdaq: ERAS) today announced four poster presentations at the 34th EORTC-NCI-AACR (ENA) Symposium on molecular targets and cancer therapeutics taking place October 26-28 in Barcelona, Spain.

October 12, 2022
·
9 min read
Lavie Bio Advances its Novel Bio-fungicide Program and Applies to the U.S. EPA for Regulatory Approval

Lavie Bio Ltd today announced submitting the registration package for LAV.311, its novel bio-fungicide targeting fruit rots and powdery mildews, to the United States Environmental Protection Agency (EPA).

October 12, 2022
·
5 min read
28th Annual BIO-Europe(R) to Bring Together Over 4,300 Life Science Leaders

The 28 th annual BIO-Europe ® global life sciences partnering event will take place October 24-26, 2022 in Leipzig, Germany.

October 12, 2022
·
3 min read